NCT00405873View on ClinicalTrials.gov

Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003

PHASE2TerminatedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

AMT2003

Trial Locations (2)

79106

University Hospital Freiburg, Dept. of Internal Medicine II, Freiburg im Breisgau

79111

Clinic SanaFontis, Freiburg im Breisgau

Sponsors
All Listed Sponsors
lead

Auron Healthcare GmbH

INDUSTRY

NCT00405873 - Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 | Biotech Hunter | Biotech Hunter